Home Featured Box Office: ‘Morbius’ takes $39-M Domestically, $84-M Globally

Box Office: ‘Morbius’ takes $39-M Domestically, $84-M Globally

by Paul Ebeling

#BoxOffice #Morbius #vampire

$SNE

Jared Leto’s new movie Morbius took in $39.1-M from 4,268 theaters in its domestic box office debut, in line with expectations after lukewarm reviews. Globally, it took in $84-M.

The movie is Sony’s latest attempt to mine the comic book characters it controls as part of Marvel‘s Spider-Man universe following the smash success of its Spider-Man and Venom movies.

Insiders stress that Morbius is not a traditional superhero offering, but a dark, genre thriller revolving around a vampire.

Morbius cost a reported $75-M to make before marketing, far less than a marquee superhero offering such as Spider-Man: No Way Home, and also less than Venom. Males fueled the film (60%), while nearly 70% of ticket buyers were between ages 18-34.

Morbius holds just a 17% rating on Rotten Tomatoes from critics. Audiences are also mixed, giving it a C+ CinemaScore, while exit scores on PostTrak are likewise mediocre. The audience score on Rotten Tomatoes is 67%.

Morbius won the weekend, both domestically and internationally. So far, there is no talk of a sequel.

Paramount’s The Lost City, starring Sandra Bullock and Channing Tatum, came in #2 domestically in its second frame with $14.8-M for a North American haul of $54.6-M. It has only rolled out in 17 markets so far overseas for an early foreign total of $7-M and $61.6-M worldwide.

The big player for Paramount overseas was Sonic the Hedgehog 2, which is rolling out in select markets ahead of its 8 April domestic launch. Sonic 2 opened to to $25.5-M in ticket sales from 31 markets.

Have some fun, see a movie in a theater, the chaos is over, Keep the Faith!

You may also like

logo-white

Your Trusted Source for Capital Markets & Related News

© 2024 LiveTradingNews.com – For The Traders, By The Traders – All Right Reserved.

The information contained on this website shall not be construed as (i) an offer to purchase or sell, or the solicitation of an offer to purchase or sell, any securities or services, (ii) investment, legal, business or tax advice or an offer to provide such advice, or (iii) a basis for making any investment decision. An offering may only be made upon a qualified investor’s receipt not via this website of formal materials from the Knightsbridge an offering memorandum and subscription documentation (“offering materials”). In the case of any inconsistency between the information on this website and any such offering materials, the offering materials shall control. Securities shall not be offered or sold in any jurisdiction in which such offer or sale would be unlawful unless the requirements of the applicable laws of such jurisdiction have been satisfied. Any decision to invest in securities must be based solely upon the information set forth in the applicable offering materials, which should be read carefully by qualified investors prior to investing. An investment with Knightsbridge is not suitable or desirable for all investors; investors may lose all or a portion of the capital invested. Investors may be required to bear the financial risks of an investment for an indefinite period of time. Qualified investors are urged to consult with their own legal, financial and tax advisors before making any investment. Knightsbridge is a private investment firm that offers investment services to Qualified Investors, Members and Institutions ONLY. Qualified Investors are defined as individuals who have met those Qualifications in the relevant jurisdictions. Members are defined as individuals who have been accepted into the Knightsbridge membership program. Institutions are defined as entities such as banks, pension funds, and hedge funds. If you are not a Qualified Investor, Member or Institution, you are not eligible to invest with Knightsbridge. All investments involve risk, and there is no guarantee of profit. You may lose some or all of your investment. Past performance is not indicative of future results. Knightsbridge is not a registered investment advisor, and this disclaimer should not be construed as investment advice. Please consult with a qualified financial advisor before making any investment decisions. By accessing this website, you agree to the terms of this disclaimer. Thank you for your interest in Knightsbridge.